Thiamphenicol in the treatment of chancroid: a study of 1.128 cases
Rev. Inst. Med. Trop. Säo Paulo
;
42(3): 133-5, May-Jun. 2000. tab
Article
Dans Anglais
| LILACS
| ID: lil-262690
ABSTRACT
Thiamphenicol, an aminic derivate of hydrocarbilsulfonil propandiol, was used for the treatment of 1,171 chancroid bearing patients. Each patient was medicated with 5.0 g of granulated thiamphenicol, orally, in a single dose, and was reevaluated 3, 7 and 10 days after the treatment. Ten patients (0.89 percent) did not respond to the proposed treatment. 133 patients presented healed ulcers after 3 days of treatment, 976 patients healed chancres on the seventh day after the treatment, and 39 patients took 10 days to present healed chancres. The results of this study indicate that the rate of patients that were cured, the low incidence of side effects, and the practicality of administration make of thiamphenicol an excellent choice for the treatment of chancroid.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Thiamphénicol
/
Chancre mou
/
Antibactériens
Limites du sujet:
Adolescent
/
Adulte
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Rev. Inst. Med. Trop. Säo Paulo
Thème du journal:
Médecine tropicale
Année:
2000
Type:
Article
Pays d'affiliation:
Brésil
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS